home / stock / tech / tech news


TECH News and Press, Bio-Techne Corp

Stock Information

Company Name: Bio-Techne Corp
Stock Symbol: TECH
Market: NASDAQ
Website: bio-techne.com

Menu

TECH TECH Quote TECH Short TECH News TECH Articles TECH Message Board
Get TECH Alerts

News, Short Squeeze, Breakout and More Instantly...

TECH - Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q4 2025 Update

2026-02-26 07:06:20 ET This article is part of a series that provides an ongoing analysis of the changes made to Ruane, Cunniff & Goldfarb’s 13F portfolio on a quarterly basis. It is based on their regulatory 13F form filed on 02/13/2026. Please visit our Tracking Ruane...

TECH - Notable healthcare headlines for the week: J&J, Masimo and Bayer in focus

2026-02-22 09:05:35 ET More on State Street Health Care Select Sector SPDR ETF VT: Still The Best Approach To Passive Investing Market Sector Review: Extreme Market Bifurcation Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More ...

TECH - Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge?Based Immunoassays for European Clinical Laboratories

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories PR Newswire Ella benchtop instrument is now CE-IVD marked and available for sale in the EU Enables diagnostic assay developers to le...

TECH - Notable healthcare headlines for the week: AstraZeneca, CVS Health, and Moderna in focus

2026-02-15 09:05:11 ET More on State Street Health Care Select Sector SPDR ETF Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More CMS Rates Proposal Shatters Health Insurance Stocks: What Investors Must Know (& Do) Insurers Brac...

TECH - Bio-Techne Announces Changes to its Leadership Team

Bio-Techne Announces Changes to its Leadership Team PR Newswire Dr. Matt McManus to transition from his role as President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 Steve Crouse, Senior Vice President of Bio-Techne's Analytical Solutions Division, has been...

TECH - Nasdaq, S&P, Dow futures rise ahead of key macroeconomic reports

2026-02-09 04:25:17 ET More on markets Monthly Macro Monitor: Plus ça Change 10th Man Report: AI Bubble And AI Recession Risks May Be Overstated S&P 500: From One Extreme To Another And No End In Sight  (Technical Analysis) Trump files $10B laws...

TECH - Bio-Techne signals mid-single-digit underlying growth for fiscal 2026, with margin expansion and cell therapy normalization ahead

2026-02-04 13:31:56 ET More on Bio-Techne Bio-Techne Corporation (TECH) Q2 2026 Earnings Call Transcript Bio-Techne Corporation (TECH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Bio-Techne: Recovery Likely Coming, But Is There Enough Re-Rati...

TECH - Bio-Techne Corporation (TECH) Q2 2026 Earnings Call Transcript

2026-02-04 13:30:53 ET Bio-Techne Corporation (TECH) Q2 2026 Earnings Call February 4, 2026 9:00 AM EST... Read the full article on Seeking Alpha For further details see: Bio-Techne Corporation (TECH) Q2 2026 Earnings Call Transcript

TECH - Bio-Techne (TECH) Q2 2026 Earnings Call Transcript

2026-02-04 10:38:08 ET Image source: The Motley Fool. Wednesday, February 4, 2026 at 9:00 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

TECH - Bio-Techne Non-GAAP EPS of $0.46 beats by $0.03, revenue of $295.88M beats by $5.41M

2026-02-04 06:35:16 ET More on Bio-Techne Bio-Techne Corporation (TECH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Bio-Techne: Recovery Likely Coming, But Is There Enough Re-Rating Potential? Bio-Techne Corporation (TECH) Presents at 53rd An...

Next 10